110 likes | 141 Views
The enfortumab vedotin brought by Seattle Genetics and Astellas is expected to bring a good news to bladder cancer patients. This is an antibody drug conjugate (ADC) under development. <br>Learn more about ADC at https://www.creative-biolabs.com/resource/adc/pdf/com/downloads/HER2-ADC-preparation-and-potency-evaluation-Creative-Biolabs.pdf<br><br>
E N D
Antibody-Drug Conjugate Address: 45-1 Ramsey Road, Shirley, NY 11967, USA Tel: 1-631-871-5806 Fax: 1-631-207-8356 Email: info@creative-biolabs.com Web: www.creative-biolabs.com/adc
Creative Biolabs’ ADC Platforms PtLnX™: Pt-based Conjugation 3D Cell Culture Hydra Linker
Creative Biolabs’ ADC Services ADC Antibody Screening DrugLnk™ Custom Synthesis Antibody Design and Conjugation ADC in vitro Analysis ADC in vivo Analysis Antibody-based Probes ADC Manufacturing
One-stop Antibody-drug Conjugate Solutions Address: 45-1 Ramsey Road, Shirley, NY 11967, USA Tel: 1-631-871-5806Fax: 1-631-207-8356 Email: info@creative-biolabs.com Web: www.creative-biolabs.com/adc